INTERPHEX Live 2021 Session: “Pros and Cons of Global Fill-Finish”
Responding to the COVID-19 pandemic, governments and public health agencies worldwide are developing quality vaccine programs, including local fill-finish capacity, to support global immunization. Yet even before COVID, countries were already facing increased vaccine demand due to population growth. The panel will discuss key challenges and opportunities as governments and pharmaceutical manufacturers seek to establish fill-finish facilities around the world to enable access to greater and more diversified vaccine manufacturing while improving preparedness to respond to future pandemics.
- Ed Kelley, PhD, former Director of Integrated Health Services for WHO; Chief Global Health Officer, ApiJect
- Jason Collins, AIA, Director of Process Architecture, IPS-Integrated Project Services
- Omair Ahmed, Chief Strategy Officer, Nexus Pharmaceuticals